Cargando…
Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
The potent antiangiogenic pigment epithelium-derived factor (PEDF) has shown promise against osteosarcoma, a tumour that originates in the bone and metastasises to the lungs. Neurotrophic, antiangiogenic, antiproliferative, and antimetastatic properties of PEDF have been attributed to a number of fu...
Autores principales: | Broadhead, Matthew L., Choong, Peter F. M., Dass, Crispin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369529/ https://www.ncbi.nlm.nih.gov/pubmed/22701300 http://dx.doi.org/10.1155/2012/230298 |
Ejemplares similares
-
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
por: Broadhead, M L, et al.
Publicado: (2011) -
Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
por: Chandolu, Vijay, et al.
Publicado: (2012) -
The Emerging Role of PEDF in Stem Cell Biology
por: Elahy, Mina, et al.
Publicado: (2012) -
The Molecular Pathogenesis of Osteosarcoma: A Review
por: Broadhead, Matthew L., et al.
Publicado: (2011) -
PEDF and PEDF-derived peptide 44mer stimulate cardiac triglyceride degradation via ATGL
por: Zhang, Hao, et al.
Publicado: (2015)